Frazier Life Sciences Management, L.P. Arvinas, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Arvinas, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 285,331 shares of ARVN stock, worth $5.15 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
285,331
Previous 285,331
-0.0%
Holding current value
$5.15 Million
Previous $7.6 Million
7.48%
% of portfolio
0.38%
Previous 0.45%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
231Shares Held
68.5MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$126 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$121 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$113 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$69.6 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$50.2 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $960M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...